SAGE

Sage Therapeutics
SAGE

Overview Fund Activity
Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

134 hedge funds and large institutions have $1.15B invested in Sage Therapeutics in 2015 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 58 increasing their positions, 32 reducing their positions, and 18 closing their positions.

Holders
134
Holders Change
+11
Holders Change %
+8.94%
% of All Funds
3.75%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
30
Increased
58
Reduced
32
Closed
18
Calls
$10.7M
Puts
$4.7M
Net Calls
+$6.04M
Net Calls Change
+$13M

Top Buyers

1
RG
1
Redmile Group
California
$48.4M
2
Franklin Resources
2
Franklin Resources
California
$43.7M
3
DM
3
Deerfield Management
New York
$27.5M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$31M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$47.9M

Top Sellers

1
TRV
1
Third Rock Ventures
Massachusetts
$273M
2
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$11M
3
DCM
3
Driehaus Capital Management
Illinois
$0
4
GGHC
4
Gilder Gagnon Howe & Co
New York
$34.6M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
JG
151
Jefferies Group
New York
– – – –
KCPG
152
Kavar Capital Partners Group
Kansas
$0 5 +5 New
Fifth Third Bancorp
153
Fifth Third Bancorp
Ohio
$0 11 +11 New
3 4 5 6
7